Cardiology Devices - Romania

  • Romania
  • The projected revenue for the Cardiology Devices market market in Romania is estimated to reach US$294.10m in 2024.
  • It is expected to experience an annual growth rate of 5.79% from 2024 to 2029, resulting in a market volume of US$389.70m by 2029.
  • When compared globally, the United States is anticipated to generate the highest revenue of US$25,770.00m in 2024.
  • Romania is experiencing a growing demand for advanced cardiology devices, driven by an aging population and increased awareness of cardiovascular health.

Key regions: United Kingdom, United States, France, Spain, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cardiology Devices market in Romania is experiencing steady growth due to a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Cardiology Devices market in Romania are influenced by several factors. Firstly, there is a growing demand for advanced and innovative medical devices that can provide accurate diagnoses and effective treatments for cardiovascular diseases. Patients and healthcare professionals alike are seeking devices that can improve patient outcomes and quality of life. Additionally, there is a preference for minimally invasive procedures and devices that can reduce the need for invasive surgeries, leading to shorter recovery times and lower healthcare costs. Trends in the market are also contributing to its development in Romania. One notable trend is the increasing adoption of digital health technologies, such as wearable devices and remote monitoring systems. These technologies allow for real-time monitoring of patients' cardiovascular health, enabling early detection of potential issues and timely interventions. Another trend is the integration of artificial intelligence and machine learning algorithms into cardiology devices, which can enhance diagnostic accuracy and treatment planning. Local special circumstances in Romania are also playing a role in the development of the Cardiology Devices market. The country has a high prevalence of cardiovascular diseases, including hypertension, ischemic heart disease, and heart failure. This creates a significant demand for cardiology devices and related treatments. Additionally, Romania has been investing in improving its healthcare infrastructure and expanding access to healthcare services, which further drives the demand for cardiology devices. Underlying macroeconomic factors are also contributing to the growth of the Cardiology Devices market in Romania. The country has been experiencing steady economic growth, which has led to increased healthcare spending. As the economy continues to develop, more resources are being allocated to the healthcare sector, including investments in medical devices and technologies. Furthermore, Romania is part of the European Union, which provides access to a larger market and facilitates trade and regulatory harmonization. In conclusion, the Cardiology Devices market in Romania is developing due to customer preferences for advanced and minimally invasive devices, market trends such as digital health technologies and artificial intelligence, local special circumstances including a high prevalence of cardiovascular diseases and investments in healthcare infrastructure, and underlying macroeconomic factors such as economic growth and EU membership. These factors are driving the demand for cardiology devices and creating opportunities for market growth in Romania.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)